SECAUCUS, N.J.--(BUSINESS WIRE)--Caligor Rx, a leading provider of services that enable pharmaceutical and biotechnology companies to maximize the value of their clinical supply chain investments, today announced that it has named Michael P. Dallmann as Director of Strategic Planning, a new position for the Company. Mr. Dallmann, who served as Director, Global Clinical Trial Supply for Cubist Pharmaceuticals, will be responsible for developing and implementing Caligor’s strategy across all lines of business, including comparator sourcing, TrialAssist™ and Global Access Programs.
